This combined medication regimen significantly improves the eradication rate of Helicobacter pylori, resulting in effective treatment outcomes for Hp-infected peptic ulcers, with a shorter time to symptom subsidence than that in the control group.16 Here, HP is linked to peptic ulcer disease.